Cytokine production and mRNA expression by conjunctival T-cell lines in chronic allergic eye disease

Clinical and Experimental Allergy

Volumn 29, Issue 9, 1999, Pages 1214-1222

  Calder, V L ^a   Jolly, G ^a   Hingorani, M ^a,b   Adamson, P ^a   Leonardi, A ^c   Secchi, A G ^c   Buckley, R J ^b   Lightman, S ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b MOORFIELDS EYE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

Author keywords

Atopic keratoconjunctivitis; Cytokines; Giant papillary conjunctivitis; T cells; Vernal keratoconjunctivitis

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; HLA DQ ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; MESSENGER RNA;

ADULT; ALLERGIC DISEASE; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EOSINOPHIL; FEMALE; FLOW CYTOMETRY; HELPER CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOPATHOGENESIS; IMMUNOPHENOTYPING; KERATOCONJUNCTIVITIS; MALE; MAST CELL; PAPILLARY CONJUNCTIVITIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; VERNAL CONJUNCTIVITIS;

ADULT; BIOPSY; CELL CULTURE TECHNIQUES; CELL LINE; CHRONIC DISEASE; CLONE CELLS; CONJUNCTIVA; CONJUNCTIVITIS, ALLERGIC; CYTOKINES; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; T-LYMPHOCYTES;

EID: 0032839462     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.1999.00585.x     Document Type: Article

References (51)

1. Tuft SJ, Kemeny MD, Dart JKG, Buckley RJ. Clinical features of atopic keratoconjunctivitis. Ophthalmol 1991; 98:150-8.
2. Bonini S. IgE and non-IgE mechanisms in ocular allergy. Ann Allergy 1993; 71:296-9.
3. Morgan G. The pathology of vernal conjunctivitis. Trans Ophthalmol Soc UK 1971; 91:467-78.
4. Bhan AK, Fujikawa I.S, Foster CS. T cell subsets and Langerhans cells in normal and diseased conjunctiva. Am J Ophthalmol 1982; 94:205-12.
5. Foster CS, Rice BA, Dutt JE. Immunopathology of atopic conjunctivitis. Ophthalmol 1991; 98:1190-6.
6. Metz DP, Bacon AS, Holgate S, Lightman SL. Phenotypic characterization of T cells infiltrating the conjunctiva in chronic allergic eye diseases. J Allergy Clin Immunol 1996; 98:686-96.
7. Buckley R J. Vernal keratoconjunctivitis. Int Ophthalmol Clin 1989; 28:303-8.
8. Foster CS, Calonge M. Atopic keratoconjunctivitis. Ophthalmol 1990; 97:992-1000.
9. Greiner JV, Fowler SA, Allansmith MR. Giant papillary conjunctivitis In: Diabezies OH, Cavanagh HD, eds. The CLAO Guide to Basic Science and Clinical Practice. New York: Grune & Stratton, 1986, 43.1-43.11.
10. Allansmith MR, Ross RN. Giant papillary conjunctivitis. Int Ophthalmol Clin 1988; 28:309-16.
11. Maggi E, Biswas P, Del Prete G, Parronchi P, Macchia D, Simonella C et al. Accumulation of TH2-like helper T cells in the conjunctiva of patients with vernal conjunctivitis. J Immunol 1991; 146:1169-74.
12. Metz DP, Hingorani M, Calder VL, Buckley RJ, Lightman SL. T cell cytokines in chronic allergic eye disease. J Allergy Clin Immunol 1998; 100:817-24.
13. Seder RA, Paul WE, Ben-Sasson SZ et al. Production of interleukin-4 and other cytokines following stimulation of mast cell lines and in vivo mast cells/basophils. Int Arch Allergy Appl Immunol 1991; 94:137-40.
14. Bradding P, Roberts JA, Britten KM et al. Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: Evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol 1994; 10:471-80.
15. Li H, Sim TC, Alam R. IL-I3 released by and localised in human basophils. J Immunol 1996; 156:4833-8.
16. + T-cell lines. J Allergy Clin Immunol 1996 97:1342-9.
17. Imada I, Estelle F, Simons R, Jay FT, Hayglass KT. Allergen-stimulated interleukin-4 and interferon-γ production in primary culture: Responses of subjects with allergic rhinitis and normal controls. Immunol 1995; 85:373-80.
18. Till S, Durham S, Dickason R et al. IL-13 production by allergen-stimulated T cells is increased in allergic disease and associated with IL-5 but not IFN-γ expression. Immunol 1997; 91:53-7.
19. Peleman R, Wu J, Fargeas C, Delespesse G. Recombinant interleukin 4 suppresses the production of interferon gamma by human mononuclear cells. J Exp Med 1989; 170:1751-6.
20. Pazdrak K, Adachi T, Alam R. Src homology protein tyrosine phosphatase (SHPTP2)/Src homology 2 phosphatase 2 (SHP2) tyrosine phosphatase is a positive regulator of the interleukin 5 receptor signal transduction pathways leading to the prolongation of eosinophil survival. J Exp Med 1997; 186:561-8.
21. Howarth PH, Redington AE, Montefort S. Pathophysiology of asthma. Allergy 1993; 48:50-6.
22. Leiferman KM. Eosinophils in atopic dermatitis. J Allergy Clin Immunol 1994; 94:1310-7.
23. Durham SR, Ying S, Varney VA et al. Cytokine messenger RNA expression for IL-3, IL-4, IL-5 and granulocyte/macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia. J Immunol 1992; 148:2390-4.
24. Abelson MB, Madiwale N, Weston JH. Conjunctival cosinophils in allergic ocular disease. Arch Ophthalmol 1983; 101:555-6.
25. Abelson MB, Shaefer K. Conjunctivitis of allergic origin: Immunologic mechanisms and current approaches to therapy. Surv Ophthalmol 1993; 38:115-32.
26. Allansmith MR, Baird RS, Greiner JV. Vernal conjunctivitis and contact lens- associated giant papillary conjunctivitis compared and contrasted. Am J Ophthalmol 1979; 87:544-55.
27. Trocme SD, Kephart GM, Bourne WM, Buckley RJ, Gleich GJ. Eosinophil major basic protein deposition in corneal ulcers associated with vernal keratoconjiinctivitis. Am J Ophthalmol 1993; 115:640-3.
28. Trocme SD, Gleich GJ, Kephart GM, Zeiske JD. Eosinophil granule major basic protein inhibition of corneal epithelial wound healing. Invest Ophthalmol Vis Sci 1994; 35:3051-6.
29. Hingorani M, Calder V, Jolly G, Buckley RJ, Lightman SL. Eosinophil surface antigen expression and cytokine production vary in different ocular allergic diseases. J Allergy Clin Immunol 1998; 102:821-30.
30. de Vries JE, Zurawski G. Immunoregulatory properties of IL-13: Its potential role in atopic disease. Int Arch Allergy Immunol 1995; 106:175-9.
31. + THO, TH1 and TH2 T cell clones and EBV-transformed B cells. Int Immunol 1995; 7:1405-16.
32. Katagiri K, Itami S, Hatano Y, Takayasu S. Increased levels of IL-13 mRNA, but not IL-4 mRNA niRNA, are found in vivo in peripheral blood mononuclear cells (PBMC) of patients with atopic dermatitis (AD). Clin Exp Immunol 1997; 108:289-94.
33. Allansmith MR, Hahn GS, Simon MA. Tissue, tear and serum IgE concentrations in vernal conjunctivitis. Am J Ophthalmol 1976; 81:506-11.
34. Samra Z, Zavaro A, Barishak Y, Sompolonsky D. Vernal keratoconjunctivitis. The significance of IgE levels in tears and serum. Int Arch Allergy Appl Immunol 1984; 74:158-64.
35. Easty DL, Birkenshaw M, Merrett T, Merrett J, Entwhistle C, Amer B. Immunological investigations in vernal eye disease. Trans Ophthalmol Soc UK 1980; 100:98-107.
36. Brauringer GE, Centifano YM. IgE in human tears. Am J Ophthalmol 1971; 72:558-61.
37. Sompolinsky D, Samra Z, Zavaro A, Banshak RA. Contribution to the immunopathology of vernal keratoconjunctivitis. Documenta Opbthahnol 1982; 53:61-92.
38. Ballow M, Mendelson L. Specific IgE antibodies in tear secretion of patients with vernal conjunctivitis. J Allergy Clin Immunol 1980; 66:112-8.
39. Katz Y, Stav D, Baar J, Passwell JH IL-13 results in differential regulation of the complement proteins C3 and factor B in tumour necrosis factor (TNF)-stimulated fibroblasts. Clin Exp Immunol 1995; 101:150-6.
40. Mondino BJ, Phinney R. The complement system in ocular allergy. Int Ophthalmol Clin 1988; 28:329-31.
41. Ballow M, Donshik PC, Mendelson L. Complement proteins and C3 anaphylotoxin in the tears of patients with conjunctivitis. J Allergy Clin Immunol 1985; 76:473-6.
42. Collin HB, Allansmith MR. Basophils in vernal conjunctivitis in humans: An electron microscope study. Invest Ophthalmol Vis Sci 1977; 16:858-64.
43. Akova YA, Rodriguez A, Foster CS. Atopic keratoconjunctivitis. Ocular Immunol Inflammation 1994; 2:125-44.
44. Leonardi A, Abatangelo G, Cortivo R, Secchi AG. Collagen types I and III in giant papillae of vernal conjunctivitis. Br J Ophthalmol 1995; 79:482-5.
45. Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse T helper cell. IV. TH2 clones secrete a factor that inhibits cytokine production by TH1 clones. J Exp Med 1989; 170:2081-5.
46. Del Prete G, De Carli M, Almerigogna F, Giudizi MG, Biagiotti R, Romagnani S. Human IL-10 is produced by both type 1 helper (TH1) and type 2 helper (TH2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 1993; 150:353-60.
47. Robinson DS, Tsicopoulos A, Meng Q, Durham D.S, Kay AB, Hamid Q. Increased interleukin-10 messenger RNA expression in atopic allergy and asthma. Am J Respir Cell Mol Biol 1996; 14:113-7.
48. Pretolani M, Goldman M. IL-10: a potential therapy for allergic inflammation? Immunol Today 1997; 18:277-80.
49. Powrie F, Menon S, Coffmann RL. Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo. Eur J Immunol 1993; 23:2223-9.
50. + T cells. Immunity 1994; 1:553-62.
51. Muhaya M, Calder V, Towler HMA, Shaer B, McLauchlan M, Lightman S. Characterization of T cells and cytokines in the aqueous humour in patients with Fuchs heterochromic cyclitis and idiopathic anterior uveitis. Clin Exp Immunol 1998; 111:123-8.